Vitreoretinal surgery for complications of choroidal tumor biopsy.

Details

Serval ID
serval:BIB_585BBABD59D7
Type
Article: article from journal or magazin.
Collection
Publications
Title
Vitreoretinal surgery for complications of choroidal tumor biopsy.
Journal
Ophthalmology
Author(s)
Grixti A., Angi M., Damato B.E., Jmor F., Konstantinidis L., Groenewald C., Heimann H.
ISSN
1549-4713 (Electronic)
ISSN-L
0161-6420
Publication state
Published
Issued date
2014
Peer-reviewed
Oui
Volume
121
Number
12
Pages
2482-2488
Language
english
Notes
Publication types: Journal ArticlePublication Status: ppublish
Abstract
OBJECTIVE: To determine the outcomes of vitreoretinal surgery after choroidal tumor biopsy.
DESIGN: Retrospective, single-center, consecutive case series.
PARTICIPANTS: A total of 739 consecutive patients undergoing choroidal tumor biopsy.
METHODS: All subjects who underwent transretinal or transscleral choroidal tumor biopsy for diagnostic or prognostic purposes between May 1993 and May 2013 were identified in our database. We then reviewed patients who subsequently required secondary vitreoretinal surgery for complications arising from such biopsies.
MAIN OUTCOME MEASURES: Reason for vitreoretinal surgery, association with biopsy procedure, best-corrected visual acuity (BCVA; logarithm of the minimum angle of resolution [logMAR]), intraocular or extrascleral tumor dissemination, resolution of vitreous hemorrhage, reattachment of the retina with a single vitreoretinal procedure, number of additional vitrectomies undertaken, and number of enucleations.
RESULTS: A total of 20 of 739 eyes (2.7%) underwent vitreoretinal surgery for complications arising from choroidal tumor biopsy. The tumors consisted of choroidal melanoma in all 20 eyes. The reasons for the secondary surgery included persistent vitreous hemorrhage in 1.9% (14/739), rhegmatogenous retinal detachment in 0.7% (5/739), and endophthalmitis in 0.14% (1/739). Median BCVA improved from 2.0 logMAR (mean, 1.92 logMAR; range, 0.8-2.7 logMAR) before vitrectomy to 0.72 logMAR (mean, 0.88 logMAR; range, -0.14 to 2.7 logMAR) after vitrectomy and 0.76 logMAR (mean, 1.14 logMAR; range, 0.1-3.0 logMAR) at the final visit (P < 0.0001, t test). Permanent resolution of vitreous hemorrhage was achieved in 6 of 14 patients, and reattachment of the retina was achieved in 2 of 5 patients after the first vitrectomy. A median of 1 (mean, 1.5; range, 1-3) additional vitrectomy was performed. Enucleation was necessary in 3 of 20 eyes (15%). There were no cases of intraocular invasion or extrascleral extension after vitrectomy.
CONCLUSIONS: Vitrectomy for complications of choroidal tumor biopsy is rare. Such corrective surgery is complex and is best undertaken by specialized ocular oncologists or vitreoretinal surgeons with experience in managing this problem.
Keywords
Adult, Aged, Aged, 80 and over, Biopsy/adverse effects, Biopsy/methods, Choroid Neoplasms/diagnosis, Endophthalmitis/etiology, Endophthalmitis/surgery, Female, Humans, Male, Melanoma/diagnosis, Middle Aged, Retinal Detachment/etiology, Retinal Detachment/surgery, Retrospective Studies, Visual Acuity, Vitreoretinal Surgery/methods, Vitreous Hemorrhage/etiology, Vitreous Hemorrhage/surgery
Pubmed
Web of science
Create date
06/02/2015 8:34
Last modification date
10/09/2019 9:30
Usage data